JP2015508099A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015508099A5 JP2015508099A5 JP2014558733A JP2014558733A JP2015508099A5 JP 2015508099 A5 JP2015508099 A5 JP 2015508099A5 JP 2014558733 A JP2014558733 A JP 2014558733A JP 2014558733 A JP2014558733 A JP 2014558733A JP 2015508099 A5 JP2015508099 A5 JP 2015508099A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- conr
- conditions
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261601101P | 2012-02-21 | 2012-02-21 | |
| US61/601,101 | 2012-02-21 | ||
| PCT/US2012/070252 WO2013126132A1 (en) | 2012-02-21 | 2012-12-18 | Cyclic diaminopyrimidine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015508099A JP2015508099A (ja) | 2015-03-16 |
| JP2015508099A5 true JP2015508099A5 (https=) | 2016-12-08 |
| JP6059260B2 JP6059260B2 (ja) | 2017-01-11 |
Family
ID=47459190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014558733A Expired - Fee Related JP6059260B2 (ja) | 2012-02-21 | 2012-12-18 | 環状ジアミノピリジン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9073944B2 (https=) |
| EP (1) | EP2817306B1 (https=) |
| JP (1) | JP6059260B2 (https=) |
| CN (1) | CN104254531B (https=) |
| AR (1) | AR090103A1 (https=) |
| AU (1) | AU2012370450B2 (https=) |
| CA (1) | CA2865040C (https=) |
| ES (1) | ES2552518T3 (https=) |
| IL (1) | IL233986A (https=) |
| WO (1) | WO2013126132A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2955612C (en) | 2014-07-18 | 2022-05-17 | Advaxis, Inc. | Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer |
| SMT202100573T1 (it) | 2016-12-22 | 2021-11-12 | Calithera Biosciences Inc | Composizioni e metodi per l'inibizione dell'attivita' dell'arginasi |
| US20220143049A1 (en) | 2019-03-21 | 2022-05-12 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| KR20220153582A (ko) * | 2020-02-14 | 2022-11-18 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 마크로시클릭 ulk1/2 억제제 |
| CN116528877A (zh) * | 2020-10-05 | 2023-08-01 | 默克专利股份公司 | 用于治疗血液障碍和实体瘤的lmp7选择性抑制剂 |
| JP7556310B2 (ja) * | 2021-02-26 | 2024-09-26 | スズキ株式会社 | 電動車両 |
| EP4312978A2 (en) | 2021-03-27 | 2024-02-07 | TRX Biosciences Limited | Compositions having improved bioavailability of therapeutics |
| US20250000859A1 (en) | 2021-08-25 | 2025-01-02 | Alesta Therapeutics BV | Use of gcn2 inhibitors in treating cancer |
| JP2025509680A (ja) * | 2022-03-14 | 2025-04-11 | ティーアールエックス バイオサイエンシズ リミテッド | 治療薬のバイオアベイラビリティを改善した組成物およびその使用 |
| TW202404979A (zh) * | 2022-07-18 | 2024-02-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 抑制並誘導ｅｇｆｒ降解的大環類化合物、其製備方法及其在醫藥上的應用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| BR9707495A (pt) | 1996-02-13 | 1999-07-27 | Zeneca Ltd | Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente |
| US6291455B1 (en) | 1996-03-05 | 2001-09-18 | Zeneca Limited | 4-anilinoquinazoline derivatives |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| NZ522074A (en) | 2000-05-31 | 2004-06-25 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| IL153484A0 (en) | 2000-07-07 | 2003-07-06 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors |
| CN1255392C (zh) | 2000-07-07 | 2006-05-10 | 安吉奥金尼药品有限公司 | 作为血管生成抑制剂的秋水仙醇衍生物 |
| CN1863780A (zh) * | 2002-08-14 | 2006-11-15 | 沃泰克斯药物股份有限公司 | 蛋白激酶抑制剂及其应用 |
| MXPA06001098A (es) * | 2003-07-29 | 2006-04-24 | Irm Llc | Compuestos y composiciones utiles como inhibidores de proteina cinasa. |
| BRPI0413018B8 (pt) * | 2003-07-30 | 2021-05-25 | Rigel Pharmaceuticals Inc | composto, e, uso de um composto |
| GB0321710D0 (en) * | 2003-09-16 | 2003-10-15 | Novartis Ag | Organic compounds |
| CA2631875A1 (en) * | 2005-12-06 | 2007-10-04 | Rigel Pharmaceuticals, Inc. | Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| ES2439948T3 (es) * | 2006-02-17 | 2014-01-27 | Rigel Pharmaceuticals, Inc. | Compuestos de 2,4-pirimidindiamina para el tratamiento o la prevención de enfermedades autoinmunitarias |
| EP2420505A1 (en) * | 2006-11-21 | 2012-02-22 | Rigel Pharmaceuticals, Inc. | Prodrug salts of 2, 4- pyrimidinediamine compounds and their uses |
| US8815872B2 (en) | 2008-09-08 | 2014-08-26 | Merck Patent Gmbh | Macrocyclics pyrimidines as aurora kinase inhibitors |
-
2012
- 2012-12-18 ES ES12808646.9T patent/ES2552518T3/es active Active
- 2012-12-18 CA CA2865040A patent/CA2865040C/en active Active
- 2012-12-18 WO PCT/US2012/070252 patent/WO2013126132A1/en not_active Ceased
- 2012-12-18 AU AU2012370450A patent/AU2012370450B2/en not_active Ceased
- 2012-12-18 CN CN201280070330.7A patent/CN104254531B/zh not_active Expired - Fee Related
- 2012-12-18 US US14/379,625 patent/US9073944B2/en active Active
- 2012-12-18 EP EP12808646.9A patent/EP2817306B1/en active Active
- 2012-12-18 JP JP2014558733A patent/JP6059260B2/ja not_active Expired - Fee Related
-
2013
- 2013-02-21 AR ARP130100516 patent/AR090103A1/es unknown
-
2014
- 2014-08-06 IL IL233986A patent/IL233986A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015508099A5 (https=) | ||
| JP2015529657A5 (https=) | ||
| JP2015509512A5 (https=) | ||
| ES2927777T3 (es) | Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP | |
| US9783513B2 (en) | STAT3 inhibitors and their anticancer use | |
| JP2015508086A5 (https=) | ||
| JP2014513729A5 (https=) | ||
| JP2012507522A5 (https=) | ||
| JP2015508085A5 (https=) | ||
| JP2014510774A5 (https=) | ||
| WO2019177975A1 (en) | Antibiotics effective for gram-negative pathogens | |
| RU2013148146A (ru) | Производные адамантила | |
| CN111727042A (zh) | 微管蛋白抑制剂 | |
| AU2016324495A1 (en) | Carborane compounds and methods of use thereof | |
| JP2020002165A (ja) | ジピコリルアミン誘導体及びそれらの薬学的使用 | |
| US9340501B2 (en) | Marinopyrrole derivatives as anticancer agents | |
| WO2023086365A1 (en) | Compositions comprising amino lipid compounds and methods of making and use thereof | |
| JPWO2020102576A5 (https=) | ||
| WO2023141538A1 (en) | Compositions comprising lipid compounds and methods of making and use thereof | |
| CN113347979B (zh) | 碳硼烷化合物、碳硼烷类似物及其使用方法 | |
| JPWO2020102100A5 (https=) | ||
| US8871983B2 (en) | Lipid compounds for suppression of tumorigenesis | |
| WO2019102054A1 (es) | Análogos no glicosídicos de alfa-galactosilceramida como activadores de células nkt | |
| US20160214941A1 (en) | Compounds for lnhibition of Unregulated Cell Growth | |
| US20250289837A1 (en) | Mitochondriotropic heteroaryl benzamide potassium channel kv1.3 inhibitors |